Patents Assigned to Capital Rx, Inc.
  • Patent number: 12430353
    Abstract: This disclosure enables (1) creation of various tags and (2) tagging of various data structures identified above with such tags. Therefore, once tagged, these data structures can be processed by various application programs, without reprograming of these application programs or with minimal reprogramming of these application programs, because these tags accommodate or account for potential changes to these data structures (e.g., in format) that are made before these data structure are received for processing, as explained above. For example, some of such tags may be business user defined categorizations of data structures that can be evaluated during processing of some of such data structures and subsequently used as inputs to a standardized logic, thereby eliminating of reprogramming of these application programs or minimizing reprogramming of these application programs.
    Type: Grant
    Filed: May 1, 2024
    Date of Patent: September 30, 2025
    Assignee: Capital Rx, Inc.
    Inventors: Anthony J. Loiacono, Joseph Alexander, Ryan Kelly
  • Patent number: 11983192
    Abstract: This disclosure enables (1) creation of various tags and (2) tagging of various data structures identified above with such tags. Therefore, once tagged, these data structures can be processed by various application programs, without reprograming of these application programs or with minimal reprogramming of these application programs, because these tags accommodate or account for potential changes to these data structures (e.g., in format) that are made before these data structure are received for processing, as explained above. For example, some of such tags may be business user defined categorizations of data structures that can be evaluated during processing of some of such data structures and subsequently used as inputs to a standardized logic, thereby eliminating of reprogramming of these application programs or minimizing reprogramming of these application programs.
    Type: Grant
    Filed: June 16, 2022
    Date of Patent: May 14, 2024
    Assignee: Capital Rx, Inc.
    Inventors: Anthony J. Loiacono, Joseph Alexander, Ryan Kelly